7-Phenyl-imidazoquinolin-4(5H)-one derivatives as selective and orally available mPGES-1 inhibitors.

Bioorg Med Chem

Drug Research Division, Dainippon Sumitomo Pharma. Co. Ltd, 3-1-98 Kasugade-Naka, Konohana-ku, Osaka 554-0022, Japan.

Published: June 2013

AI Article Synopsis

  • The research focused on optimizing a lead compound to enhance its mPGES-1 inhibitory activity and improve its ADME profile by making substitutions at specific positions.
  • By replacing bromine in the lead compound with different groups, the phenyl group was found to be the most effective for strong inhibitory activity and favorable ADME characteristics.
  • Ultimately, compound 39 emerged as the top candidate, demonstrating impressive mPGES-1 inhibition, potent cell activity, and excellent oral absorption in tests.

Article Abstract

To identify compounds with strong mPGES-1 inhibitory activity and clear in vitro ADME profile, we optimized the lead compound 1 by carrying our substitutions at the C(7)- and C(8)-positions. Replacement of the bromine atom of 1 with various substituents led to identification of the phenyl group as the best C(7)-substituent giving strong inhibitory activity with good in vitro ADME profile. Further SAR examination on both the C(2)- and the C(7)-phenyl groups provided compound 39 as the best candidate for further development. Compound 39 exhibited strong mPGES-1 inhibitory activity (IC50=4.1 nM), potent cell-based functional activity (IC50=33 nM) with good mPGES-1 selectivity (over 700-fold), excellent in vitro ADME profile, and good oral absorption in rat PK study.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2013.03.069DOI Listing

Publication Analysis

Top Keywords

inhibitory activity
12
vitro adme
12
adme profile
12
strong mpges-1
8
mpges-1 inhibitory
8
7-phenyl-imidazoquinolin-45h-one derivatives
4
derivatives selective
4
selective orally
4
mpges-1
4
orally mpges-1
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!